HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis
Clinical trial NCT03456817 · TERMINATED
Trial details
- NCT number
- NCT03456817
- Sponsor
- AHS Cancer Control Alberta
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2025-05-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.